ReposiTrak (TRAK) Common Equity (2011 - 2025)

ReposiTrak's Common Equity history runs 15 years deep, the most recent figure standing at $49.7 million for Q4 2025.

• On a quarterly basis, Common Equity rose 3.73% year-over-year to $49.7 million in Q4 2025; TTM through Dec 2025 was $49.7 million, a 3.73% increase from a year earlier, with the FY2025 full-year figure at $49.5 million, up 5.69% from the prior year.
• Common Equity retreated to $49.7 million in Q4 2025 per TRAK's latest filing, from $50.2 million in the prior quarter.
• Across five years, Common Equity topped out at $50.2 million in Q3 2025 and bottomed at $42.8 million in Q1 2022.
• The 5-year median for Common Equity is $45.8 million (2023), against an average of $46.2 million.
• Across the five-year window, Common Equity rose 7.16% in 2021 and retreated 5.08% in 2022, its largest moves.
• Year by year, Common Equity stood at $45.5 million in 2021, then retreated by 2.7% to $44.3 million in 2022, then advanced by 3.36% to $45.7 million in 2023, then gained by 4.79% to $47.9 million in 2024, then advanced by 3.73% to $49.7 million in 2025.
• Per Business Quant, the three latest TRAK Common Equity figures stand at $49.7 million (Q4 2025), $50.2 million (Q3 2025), and $49.5 million (Q2 2025).